Evidence map›Paper›PMID 29346385›Full record

Trial reportPLoS neglected tropical diseases2018

Combined effectiveness of anthelmintic chemotherapy and WASH among HIV-infected adults.

Arianna R Means, Lisette van Lieshout, Eric Brienen, Krista Yuhas, James P Hughes, Paul Ndungu, Benson Singa, Judd L Walson

Registry-linked trialOpen access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in PLoS neglected tropical diseases, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00507221 (Empiric Therapy of Helminth Co-infection to Reduce HIV-1 Disease Progression), which is not on this map. Cited by 4 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 2 pooled it
0.5field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00507221 nacompletednot on this map

Empiric Therapy of Helminth Co-infection to Reduce HIV-1 Disease Progression

TypeinterventionalSponsorUniversity of WashingtonRan2008 to 2011Enrolled948ConditionsHIV Infections, HelminthiasisArmsAlbendazole, Praziquantel, Current standard of care in Kenya
3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 2 syntheses or guidelines pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Anthelmintic drugs for treating ascariasis.The Cochrane database of systematic reviews · 2020
    Pooled it
  3. Trial
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 4 countries.

Arianna R MeansDepartment of Global Health, University of Washington, Seattle, WA, United States.ORCID 0000-0002-4087-7080
Lisette van LieshoutDepartment of Parasitology, Leiden University Medical Center, Leiden, Netherlands.
Eric BrienenDepartment of Parasitology, Leiden University Medical Center, Leiden, Netherlands.
Krista YuhasDepartment of Global Health, University of Washington, Seattle, WA, United States.
James P HughesDepartment of Biostatistics, University of Washington, Seattle, WA, United States.
Paul NdunguCentre for Clinical Research, Kenya Medical Research Institute (KEMRI), Nairobi, Kenya.
Benson SingaCentre for Clinical Research, Kenya Medical Research Institute (KEMRI), Nairobi, Kenya.
Judd L WalsonDepartment of Global Health, University of Washington, Seattle, WA, United States.
Kenya Medical Research Institute · KELeiden University Medical Center · NLNatural History Museum · GBUniversity of Washington · US

Funding

University of Washington/Fred Hutch Center for AIDS ResearchP30AI027757 · NIAID · UNIVERSITY OF WASHINGTON · PI EDWIN ROBERTO ORELLANA · 1988 to 2026
$104.9M
NIAID NIH HHS P30 AI027757NIH HHS P30 AI027757
6 · The paper itself

Abstract

introductionCurrent global helminth control guidelines focus on regular deworming of targeted populations for morbidity control. However, water, sanitation, and hygiene (WASH) interventions may also be important for reducing helminth transmission. We evaluated the impact of different potential helminth protective packages on infection prevalence, including repeated treatment with albendazole and praziquantel with and without WASH access. METHODOLOGY/PRINCIPAL

findingsWe conducted a cohort study nested within a randomized trial of empiric deworming of HIV-infected adults in Kenya. Helminth infections and infection intensity were diagnosed using semi-quantitative real-time PCR. We conducted a manual forward stepwise model building approach to identify if there are packages of interventions that may be protective against an STH infection of any species (combined outcome) and each helminth species individually. We conducted secondary analyses using the same approach only amongst individuals with no anthelmintis exposure. We used interaction terms to test for potential intervention synergy. Approximately 22% of the 701 stool samples provided were helminth-infected, most of which were of low to moderate intensity. The odds of infection with any STH species were lower for individuals who were treated with albendazole (aOR:0.11, 95%CI: 0.05, 0.20, p<0.001), adjusting for age and sex. Although most WASH conditions demonstrated minimal additional benefit in reducing the probability of infection with any STH species, access to safe flooring did appear to offer some additional protection (aOR:0.34, 95%CI: 0.20, 0.56, p<0.001). For schistosomiasis, only treatment with praziquantel was protective (aOR:0.30 95%CI: 0.14, 0.60, p = 0.001). Amongst individuals who were not treated with albendazole or praziquantel, the most protective intervention package to reduce probability of STH infections included safe flooring (aOR:0.34, 95%CI: 0.20, 0.59, p<0.001) and latrine access (aOR:0.59, 95%CI: 0.35, 0.99, p = 0.05). Across all species, there was no evidence of synergy or antagonism between anthelmintic chemotherapy with albendazole or praziquantel and WASH resources. CONCLUSIONS/SIGNIFICANCE: Deworming is effective in reducing the probability of helminth infections amongst HIV-infected adults. With the exception of safe flooring, WASH offers minimal additional benefit. However, WASH does appear to significantly reduce infection prevalence in adults who are not treated with chemotherapy.

trial registrationClinicalTrials.gov, NCT00507221.

Indexed as

HygieneAdolescentAdultAlbendazoleAnthelminticsChemopreventionCohort StudiesFemaleHelminthiasisHIV InfectionsHumansInfection ControlKenyaMaleMiddle AgedMolecular Diagnostic TechniquesAlbendazoleAnthelminticsPraziquantel

Identifiers

PMID29346385
PMCPMC5773082
OpenAlexW2784060892

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.